Abstract
Excess dietary salt contributes to inflammation and hypertension via poorly understood mechanisms. Antigen presenting cells including dendritic cells (DCs) play a key role in regulating intestinal immune homeostasis in part by surveying the gut epithelial surface for pathogens. Previously, we found that highly reactive γ-ketoaldehydes or isolevuglandins (IsoLGs) accumulate in DCs and act as neoantigens, promoting an autoimmune-like state and hypertension. We hypothesized that excess dietary salt alters the gut microbiome leading to hypertension and this is associated with increased immunogenic IsoLG-adduct formation in myeloid antigen presenting cells. To test this hypothesis, we performed fecal microbiome analysis and measured blood pressure of healthy human volunteers with salt intake above or below the American Heart Association recommendations. We also performed 16S rRNA analysis on cecal samples of mice fed normal or high salt diets. In humans and mice, high salt intake was associated with changes in the gut microbiome reflecting an increase in Firmicutes, Proteobacteria and genus Prevotella bacteria. These alterations were associated with higher blood pressure in humans and predisposed mice to vascular inflammation and hypertension in response to a sub-pressor dose of angiotensin II. Mice fed a high salt diet exhibited increased intestinal inflammation including the mesenteric arterial arcade and aorta, with a marked increase in the B7 ligand CD86 and formation of IsoLG-protein adducts in CD11c+ myeloid cells. Adoptive transfer of fecal material from conventionally housed high salt-fed mice to germ-free mice predisposed them to increased intestinal inflammation and hypertension. These findings provide novel insight into the mechanisms underlying inflammation and hypertension associated with excess dietary salt and may lead to interventions targeting the microbiome to prevent and treat this important disease.
Introduction
It is a well-established medical fact that high dietary sodium is a major risk factor for cardiovascular disease and hypertension. However, the exact molecular mechanisms explaining how salt triggers systemic inflammation and raises blood pressure remain poorly understood. Previous research has identified oxidative lipid byproducts called isolevuglandins (IsoLGs) that accumulate in dendritic cells (DCs)—the sentinels of the immune system—acting as neoantigens that promote an autoimmune-like state. Because the intestinal mucosa is the primary absorption site for dietary salt and is heavily patrolled by DCs, this study investigates whether excess salt alters the gut microbiome (dysbiosis), which in turn activates these gut-resident immune cells to initiate the hypertensive cascade.
Methods
The researchers used a translational approach, combining human observational data with mechanistic mouse models. The human cohort included 135 healthy volunteers whose sodium intake was categorized as normal (<2.3 g/day) or high (≥2.3 g/day) based on food frequency questionnaires. Stool samples were analyzed via 16S rRNA sequencing to profile the microbiome. In parallel, C57BL/6 mice were fed either a normal or high-salt (8% NaCl) diet. Flow cytometry was used to track immune cell infiltration and IsoLG formation in gut tissues. To prove causality, fecal microbiota transplantation (FMT) was performed from high-salt-fed mice into germ-free recipients, followed by a challenge with a subpressor dose of Angiotensin II (Ang II) to assess "priming" for hypertension.
Results
Human Findings and Microbial Shifts
Subjects consuming more than 2.3 g/day of sodium had significantly higher systolic (117.4 vs 109.0 mmHg) and diastolic (70.7 vs 65.6 mmHg) blood pressures. Microbiome analysis revealed a remarkably similar shift in both humans and mice, characterized by an increase in the Firmicutes/Bacteroidetes ratio and the genus Prevotella. Specifically, the abundance of Prevotella positively correlated with elevated systolic blood pressure in the human cohort.
Immune Activation and "Priming" in Mice
In mice, high salt markedly increased the infiltration of CD11c+ dendritic cells into the mesenteric arterial arcade. These cells showed increased activation markers (CD86) and high levels of intracellular IsoLG adducts. Crucially, the high-salt diet lowered the threshold for hypertension. When given a tiny, normally harmless subpressor dose of Ang II, mean arterial pressure in normal-salt mice stayed flat at ~100 mmHg, while in high-salt mice, it surged to ~140 mmHg, accompanied by severe aortic inflammation.
Causality via Microbiota Transfer
The FMT experiment confirmed that the microbiome is causal, not just correlated. Germ-free mice receiving microbiota from high-salt-fed donors developed significantly higher systolic BP (~160 mmHg) in response to low-dose Ang II compared to those receiving normal-salt FMT (~130 mmHg). This susceptibility was accompanied by elevated plasma inflammatory cytokines, including IL-6 and IL-17.
Discussion
This study successfully connects diet, gut bacteria, and systemic disease. The proposed pathway suggests that excess salt induces microbiome dysbiosis, leading to IsoLG accumulation in gut DCs, which then activates an inflammatory T-cell response (producing IFN-γ and IL-17) that drives systemic vascular inflammation and hypertension. While the use of germ-free mice presents some limitations due to their naive immune systems, the cross-species consistency of the microbial shifts underscores the relevance of these findings. Future interventions targeting the microbiome, such as specific probiotics to replenish beneficial lactic acid bacteria or IsoLG scavengers, could offer novel strategies for preventing and treating salt-sensitive hypertension.
Summary updated